These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 19897400)

  • 1. The RGM/DRAGON family of BMP co-receptors.
    Corradini E; Babitt JL; Lin HY
    Cytokine Growth Factor Rev; 2009; 20(5-6):389-98. PubMed ID: 19897400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repulsive guidance molecules (RGMs) and neogenin in bone morphogenetic protein (BMP) signaling.
    Tian C; Liu J
    Mol Reprod Dev; 2013 Sep; 80(9):700-17. PubMed ID: 23740870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repulsive guidance molecule RGMa alters utilization of bone morphogenetic protein (BMP) type II receptors by BMP2 and BMP4.
    Xia Y; Yu PB; Sidis Y; Beppu H; Bloch KD; Schneyer AL; Lin HY
    J Biol Chem; 2007 Jun; 282(25):18129-18140. PubMed ID: 17472960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DRAGON, a bone morphogenetic protein co-receptor.
    Samad TA; Rebbapragada A; Bell E; Zhang Y; Sidis Y; Jeong SJ; Campagna JA; Perusini S; Fabrizio DA; Schneyer AL; Lin HY; Brivanlou AH; Attisano L; Woolf CJ
    J Biol Chem; 2005 Apr; 280(14):14122-9. PubMed ID: 15671031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repulsive guidance molecule (RGM) family proteins exhibit differential binding kinetics for bone morphogenetic proteins (BMPs).
    Wu Q; Sun CC; Lin HY; Babitt JL
    PLoS One; 2012; 7(9):e46307. PubMed ID: 23029472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repulsive guidance molecules, novel bone morphogenetic protein co-receptors, are key regulators of the growth and aggressiveness of prostate cancer cells.
    Li J; Ye L; Kynaston HG; Jiang WG
    Int J Oncol; 2012 Feb; 40(2):544-50. PubMed ID: 22076499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repulsive guidance molecules lock growth differentiation factor 5 in an inhibitory complex.
    Malinauskas T; Peer TV; Bishop B; Mueller TD; Siebold C
    Proc Natl Acad Sci U S A; 2020 Jul; 117(27):15620-15631. PubMed ID: 32576689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DRAGON, a GPI-anchored membrane protein, inhibits BMP signaling in C2C12 myoblasts.
    Kanomata K; Kokabu S; Nojima J; Fukuda T; Katagiri T
    Genes Cells; 2009 Jun; 14(6):695-702. PubMed ID: 19422419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor.
    Babitt JL; Zhang Y; Samad TA; Xia Y; Tang J; Campagna JA; Schneyer AL; Woolf CJ; Lin HY
    J Biol Chem; 2005 Aug; 280(33):29820-7. PubMed ID: 15975920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The RGM protein DRAG-1 positively regulates a BMP-like signaling pathway in Caenorhabditis elegans.
    Tian C; Sen D; Shi H; Foehr ML; Plavskin Y; Vatamaniuk OK; Liu J
    Development; 2010 Jul; 137(14):2375-84. PubMed ID: 20534671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenetic protein receptor signal transduction in human disease.
    Gomez-Puerto MC; Iyengar PV; García de Vinuesa A; Ten Dijke P; Sanchez-Duffhues G
    J Pathol; 2019 Jan; 247(1):9-20. PubMed ID: 30246251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RGMs: Structural Insights, Molecular Regulation, and Downstream Signaling.
    Siebold C; Yamashita T; Monnier PP; Mueller BK; Pasterkamp RJ
    Trends Cell Biol; 2017 May; 27(5):365-378. PubMed ID: 28007423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neogenin-RGMa signaling at the growth cone is bone morphogenetic protein-independent and involves RhoA, ROCK, and PKC.
    Conrad S; Genth H; Hofmann F; Just I; Skutella T
    J Biol Chem; 2007 Jun; 282(22):16423-33. PubMed ID: 17389603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways.
    Nohe A; Hassel S; Ehrlich M; Neubauer F; Sebald W; Henis YI; Knaus P
    J Biol Chem; 2002 Feb; 277(7):5330-8. PubMed ID: 11714695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in BMP receptor signaling.
    Sieber C; Kopf J; Hiepen C; Knaus P
    Cytokine Growth Factor Rev; 2009; 20(5-6):343-55. PubMed ID: 19897402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin.
    Xia Y; Babitt JL; Sidis Y; Chung RT; Lin HY
    Blood; 2008 May; 111(10):5195-204. PubMed ID: 18326817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone morphogenetic protein signal transduction in bone.
    ten Dijke P
    Curr Med Res Opin; 2006; 22 Suppl 1():S7-11. PubMed ID: 16882364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repulsive guidance molecule is a structural bridge between neogenin and bone morphogenetic protein.
    Healey EG; Bishop B; Elegheert J; Bell CH; Padilla-Parra S; Siebold C
    Nat Struct Mol Biol; 2015 Jun; 22(6):458-65. PubMed ID: 25938661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The extracellular regulation of bone morphogenetic protein signaling.
    Umulis D; O'Connor MB; Blair SS
    Development; 2009 Nov; 136(22):3715-28. PubMed ID: 19855014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.